Skip to content

ENDO-EVE Effectively detect endometriosis and provide coordinated, holistic treatment

ENDO-EVE Effectively detect endometriosis and provide coordinated, holistic treatment - ENDO-EVE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038057
Enrollment
775
Registered
2026-06-02
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N80

Interventions

Group 1: Control group - Questionnaires + Eve Participants in the control group utilize exclusively the assessments defined in the study protocol at the designated measurement time points (T1–T8). Opt
Low-Risk Whitelist). Weekly monitoring remains active
if defined thresholds are exceeded, a brief daily check may be temporarily triggered. Coaching appointments and notifications to the treatment team remain deactivated. Recommendations generated by the
these may be offered or mandatorily triggered if predefined thresholds are exceeded. Critical actions—particularly mandatory contacts or alerts—are subject to a Human-in-the-Loop (HITL) process: a qua

Sponsors

Universitätsklinik und Poliklinik für Geburtshilfe und Pränatalmedizin
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Statutory health insurance (GKV) with one of the participating health insurance companies German skills: fluent Smartphone Typical symptoms of endometriosis such as cycle-related pain (e.g., dysmenorrhea, dyspareunia, dysuria, dyschezia, cyclic/acyclic pelvic pain, infertility) or imaging findings (ultrasound, MRI, etc.)

Exclusion criteria

Exclusion criteria: Not insured with participating health insurance companies Over the age of 50

Design outcomes

Primary

MeasureTime frame
Physical quality of life (PCS, SF-36) after 12 weeks

Secondary

MeasureTime frame
Health-related quality of life (SF-36 total score) Physical pain (SF-36 subscale) Impairment of daily life due to chronic pain (Brief Pain Inventory, BPI) Productivity (WPAI-SHP) Self-efficacy (SWE, FESS) Depressive symptoms (PHQ-9) Partnership quality (intimacy, communication) Endometriosis-specific quality of life (EHP-5) Depending on the questionnaire, secondary endpoints are collected at T1 through T8.

Countries

Germany

Contacts

Public ContactStephanie Wallwiener

Universitätsklinik und Poliklinik für Geburtshilfe und Pränatalmedizin

stephanie.wallwiener@uk-halle.de0345557-3245

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026